343333 Sigma-Aldrich5-Fluoro-2ʹ-deoxyuridine - CAS 50-91-9 - Calbiochem
Experimental anticancer agent shown to have activity against a variety of malignant neoplasms, including mouse mammary tumors and colorectal carcinomas.
More>> Experimental anticancer agent shown to have activity against a variety of malignant neoplasms, including mouse mammary tumors and colorectal carcinomas. Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: FdUrd, FUdR, 5-FdU, Floxuridine
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 50-91-9 | C₉H₁₁FN₂O₅ |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 343333-50MGCN | 50 mg |
| References | |
|---|---|
| References | Nakagama, H., et al. 2001. Jpn. J. Clin. Oncol. 31, 251. Malmberg, M., et al. 1993. Cell Prolif. 26, 291. |
| Product Information | |
|---|---|
| CAS number | 50-91-9 |
| ATP Competitive | N |
| Form | White solid |
| Hill Formula | C₉H₁₁FN₂O₅ |
| Chemical formula | C₉H₁₁FN₂O₅ |
| HS Code | 2934 99 99 |
| Reversible | N |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Experimental anticancer agent |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | YU7525000 |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 343333-50MGCN | 04055977195118 |
Documentation
5-Fluoro-2ʹ-deoxyuridine - CAS 50-91-9 - Calbiochem MSDS
| 职位 |
|---|
5-Fluoro-2ʹ-deoxyuridine - CAS 50-91-9 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 343333 |
参考
| 参考信息概述 |
|---|
| Nakagama, H., et al. 2001. Jpn. J. Clin. Oncol. 31, 251. Malmberg, M., et al. 1993. Cell Prolif. 26, 291. |



